Algatechnologies News
18 articles
AstaPure Arava® microalgae astaxanthin shows beneficial mind-body effects
A recently published clinical study demonstrated that AstaPure Arava by Solabia-Algatech Nutrition can have a beneficial effect on the immune system and global well-being. The study showed a significant reduction in the stress hormone cortisol and positive changes in the gut microbiome. AstaPure Arava is a whole-algae ingredient that contains astaxanthin and other vital nutrients naturally found in microalgae. The study involved fit adult male and female recreational runners who took either AstaPure Arava or a placebo for three weeks before and one week following a competitive marathon or half-marathon. The supplement group reported significantly fewer upper-respiratory tract complaints and better overall well-being. The study suggests that AstaPure Arava could help improve the immune systems acuity and overall sense of well-being following stress conditions.
Customers
Solabia buys Israeli microalgae co Algatechnologies
French biotech group Solabia has acquired an 80% stake in Israeli microalgae company Algatechnologies. The deal was agreed at a company valuation of $80-100 million. Solabia Group, which produces natural ingredients for cosmetics and skincare, bought the stake from Grovepoint and the JCA Charitable Foundation. Algatechnologies will become a focus of activities in ingredients for Solabias food and food additives sector. The acquisition will provide access to R&D capabilities, new marketing channels, and a broad customer base. Algatechnologies is a leading manufacturer of microalgae-based ingredients and products, selling to over 30 countries. The company plans to invest over $20 million in expanding production capabilities and developing new products.
Acquisition
Algatech Delivers Potent Astaxanthin in Whole-food Format
Algatechnologies Ltd. presents AstaPure Arava, a clean-label, all-natural whole-algae complex. The companys proprietary technology allows the microalgae to produce high levels of active compounds. The whole-algae powder, containing natural astaxanthin and a newly discovered natural complex, has been found to have potent and synergistic effects. Algatechnologies plans to introduce new innovative products and delivery forms based on the AstaPure Arava powder. The company aims to provide consumers with a concentrated, potent, and naturally balanced complex that is delivered with minimal processing and minimal footprint. Algatechnologies and NIS Labs will continue to explore the potential health benefits of the Arava whole algae powder.
CustomersPartners
Algatech Partners With Sphera on Microalgae
Algatechnologies, Ltd. is partnering with Sphera Encapsulation S.r.l to develop innovative functional ingredient formats using Spheras encapsulation technology. The partnership will focus on the development of new delivery forms of ingredients derived from microalgae. The first product, a water-soluble powder of AstaPure®, is expected to launch soon. The powder is formulated with natural ingredients and has improved bioavailability. Algatech and Sphera will introduce the new powder at Vitafoods. The collaboration aims to meet the growing demand for new delivery forms and higher value in the nutraceutical market.
Partners
Israeli Biotech Company Algatech Expands Into Asia
Israeli biotech company Algatech has acquired a controlling stake in New Zealand-based microalgae cultivation company Supreme Health. The financial terms of the deal were not disclosed. Algatech plans to use Supreme Healths existing marketing channels to launch its activity in Asia, particularly in China where there is growing demand for algae-based products. Algatech cultivates microalgae and produces natural astaxanthin, selling its products in over 35 countries. Supreme Health also cultivates microalgae for the production of natural astaxanthin. The acquisition is expected to drive growth for Algatech in the Asian market.
PartnersExpand
Algatech Offers Organic, Non-GMO Natural Astaxanthin
Algatech has announced that its organic Haematococcus pluvialis microalgae powder and astaxanthin oleoresin have been granted non-GMO verification by the Non-GMO Project Inc. This makes Algatech the first and only astaxanthin manufacturer to achieve this verification. The verification provides added value to Algatechs partners, in addition to existing certifications such as USDA organic, GMP, kosher, and halal. Algatechs astaxanthin is sourced from microalgae cultivated in the Arava desert, using eco-friendly, GMP-certified closed-system technology. The company emphasizes the importance of clean and pure algae biomass for producing high-quality products. Algatech is committed to providing the finest microalgae solutions on the market.
Partners
Algatech Opens New US Subsidiary
Algatech is opening a subsidiary in New York City called Algatech Inc. to serve its customers in the North American market. Ken Seguine has been appointed as the head of the new operation. This expansion into the U.S. will accelerate the development of the growing market in North America for Algatechs microalgae ingredient brand, AstaPure®, as well as new microalgae sources. Algatech Inc. will be responsible for the US, Canada, and Mexico. The company plans to recruit highly qualified personnel, develop new products, and expand its operation facilities in Israel. Algatech specializes in the development and production of ingredients derived from algae.
Customers
Lycored Announces Joint Venture With Algatech
Lycored announced a joint venture with Algatech, a biotechnology company and global leader in cultivating microalgae and production of natural astaxanthin. Lycored will distribute Algatechs AstaPure natural astaxanthin carotenoid in the North American market. The partnership allows Lycored to evolve its astaxanthin offerings while maintaining commitment to distributing premium quality ingredients. Astaxanthin has antioxidative and anti-inflammatory properties and potential effects on the aging process. Lycoreds North American commercialization team will market and distribute the astaxanthin beadlets for dietary supplements and use in food and beverages. The partnership comes after Lycoreds newest patent for Astaxanthin Anti-Inflammatory Synergistic Combinations.
Partners
Algatech aiming for multiple new algae-derived ingredient launches over next few years
Algatech, a company specializing in microalgae, is working on the development of five different microalgae species for commercial use. The company plans to launch these products later this year and in the following years. Algatech believes it is the expert in microalgae production and aims to develop a wide range of microalgae products. The company is participating in a pan-EU sustainable food project with 50 partners, including Puratos, Roquette, DSM, PepsiCo, and Nestec. The project aims to invest close to €1.2bn over seven years and develop new food sources from microalgae. Algatech is known for its high-quality astaxanthin derived from Haematococcus pluvialis microalgae. The company recently obtained organic certification for its microalgae powder and astaxanthin oleoresin.
Partners
Algatechnologies Introduces Whole-Algae AstaPure® Natural Astaxanthin
Algatechnologies will highlight its AstaPure 3 percent astaxanthin powder at Vitafoods 2017. The company offers a unique, whole-algae form of astaxanthin that is produced using a sustainable and patented closed-cultivation system. The manufacturing processes ensure compliance with global quality and safety standards. Algatechnologies is a manufacturer and supplier of innovative algae-based products.
CustomersPartners
Algatechnologies Partners in EIT Food - Winner of Pan-European Call
Algatechnologies Ltd has been chosen as the sole algae player to participate in the FoodConnects consortium, a pan-European competition on the Food4Future call. The consortium, consisting of 50 leading companies, universities, and scientific partners, aims to transform the way food is produced, distributed, and consumed. Algatechnologies will work within EIT Food to develop new food sources from microalgae. The partners will invest close to 1200 million euros over the next seven years, with additional financing from the EIT. Algatechnologies is in discussions with other consortium partners to select innovative algae sources with nutritional properties. The CEO of Algatechnologies, Hagai Stadler, believes that microalgae will become an increasingly important element of the future diet.
Partners
Is 2016 the year of algae?
The article discusses the potential of algae and microalgae technologies in addressing various global challenges. It highlights the leading role of Israeli companies in this field and their focus on utilizing algae for renewable fuel, animal feed, cosmetics, drug delivery, and more. The article mentions eight Israeli companies that are betting on algae for future growth. These companies include TransAlgae, Algatechnologies, Qualitas Health, Aquanos, UniVerve, Frutarom Industries, Algalo Industries, and Nature Beta Technologies. The impact of the article on these companies is growth-positive. The key theme of the article is the potential of algae and microalgae technologies. The key issues discussed in the article are investment and expansion. The article does not mention any specific investors, customers, acquisition or investment amounts, layoffs, or partners. The date of the event described in the article is not provided. Confidence level: 8/10.
InvestmentExpand
Algatechnologies Announces Verification by the Non-GMO Project
Algatech, a company that produces natural astaxanthin products, has received certification from the Non-GMO Project (NGP). This certification ensures that their products are produced in compliance with the Non-GMO Project Standard. Algatechs AstaPure brand of astaxanthin is among the first to be verified by the NGP. The company plans to make further investments in new product development and market launches in 2016. The Non-GMO Project offers independent verification for products made without genetically modified organisms (GMOs).
Customers
Algatechnologies and FujiFilm Partner on Natural Astaxanthin
Algatechnologies Ltd. (Algatech) has signed a supply and long-term collaboration agreement with Fujifilm Corp. in Japan. Fujifilm will promote astaxanthin raw materials and has been using Algatech’s natural astaxanthin as the main active ingredient for its nutrition supplement and cosmetics product line named Astalift. The partnership is expected to increase Algatechs leading position in Japan and the rest of the world.
Partners
Algae are more than just Sushi
Algatechnologies, a company that develops microalgae materials used in the cosmetic and pharmaceutical industry, was acquired by Britains Grovepoint investment fund at a valuation of $50 million. The investment fund aims to grow the company globally and sees its potential in harnessing Israeli initiative to address the worlds shortage of resources. Algatechnologies is currently focused on its future growth and is considering acquiring companies that will complement its product offering. The company has received significant investment from Grovepoint and is expanding its factory. It has also signed a cooperation agreement with Germanys Schott Corporation. Algatechnologies is seen as a model company by Grovepoint and is expected to continue growing under its new ownership.
InvestmentExpand
The powerful new antioxidant made of sun and algae
British investment firm Grovepoint Capital has invested approximately $50 million in Algatechnologies, an Israeli company that produces the antioxidant AstaPure. The investment will be used to expand production and meet the high demand for AstaPure products in the global market. Algatechnologies sales cover 30 countries, with Japan and the United States being the main consumer bases. The companys production plant, located in the Arava Valley, is powered by solar energy and utilizes a closed system for manufacturing. The investment is expected to result in the hiring of additional employees, primarily from the Arava region.
InvestmentExpand
Private Equity Acquires Stake in Natural Astaxanthin Supplier Algatechnologies
Grovepoint, a private investment company, has acquired a majority stake in Algatechnologies Ltd., a rapidly growing company specializing in the commercial cultivation of microalgae and a leading manufacturer of AstaPure, natural astaxanthin. The acquisition is valued at around US$50 million. Grovepoint plans to grow the range of products using astaxanthin as the key ingredient and invest in R&D for new algae-derived products. The transaction will also result in Grovepoint partners joining the Algatechnologies Board. Algatechnologies has developed proprietary technology for sustainable production of the AstaPure line. Grovepoint is a London-based investment firm with investments in various sectors.
Acquisition
Grovepoint buys control of Algatechnologies at $50m company value
British private equity firm Grovepoint Capital has acquired control of biotechnology company Algatechnologies Ltd. for $50 million. Algatechnologies cultivates microalgae to supply a powerful antioxidant called astaxanthin. The companys main product, AstaPure, is sold as a nutritional supplement and component in cosmetic formulas. The acquisition will support the expansion of Algatechnologies production and international marketing network, as well as the construction of another plant for the production of more microalgae-based biological substances. Grovepoint Capital plans to keep development and production in Israel. Algatechnologies shareholders are Kibbutz Ketura and the Jewish Colonization Association. The companys founders are Prof. Sammy Boussiba, Ed Hofland, and Hagay Tzur. The acquisition marks Grovepoint Capitals first major investment in Israel.
Acquisition
